Brand Name | Status | Last Update |
---|---|---|
2-oak mix, red/white pollen 3-oak mix, black/blackjack/post pollen 3-ragweed mix, giant/short/western pollen 4-pine mix, austrian/loblolly/scotch/w... | Biologic Licensing Application | 2011-03-11 |
ad incontinence support | C200263 | 2025-03-07 |
avance incontinence care | C200263 | 2024-05-11 |
bioelements, inc. | OTC monograph not final | 2012-01-17 |
ca-rezz - long term care - incontinent cleanser | C200263 | 2024-12-26 |
ca-rezz - norisc - incontinent wash | C200263 | 2024-12-27 |
center-al - acacia longifolia pollen center-al - acer negundo pollen center-al - acer saccharum pollen center-al - agrostis gigantea center-al - al... | Biologic Licensing Application | 2009-06-12 |
chain drug marketing association, inc. | C200263 | 2024-05-21 |
crooked creek distillery inc hand sanitizer | OTC monograph not final | 2020-03-25 |
cvs pharmacy,inc. | C200263 | 2024-08-16 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 32 | 1 | — | 2 | 19 | 54 |
Neoplasms | D009369 | — | C80 | 9 | 7 | 1 | 1 | 2 | 16 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 2 | 1 | — | 2 | 7 | 12 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | 1 | 10 | 11 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | 2 | 1 | 1 | 7 | 11 |
Wounds and injuries | D014947 | — | T14.8 | 3 | 2 | — | 1 | 5 | 9 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 1 | — | 2 | 5 | 8 |
Spinal cord injuries | D013119 | EFO_1001919 | — | 1 | 1 | — | 1 | 6 | 8 |
Glaucoma | D005901 | EFO_0000516 | H40 | — | 1 | 2 | 1 | 3 | 7 |
Postoperative pain | D010149 | — | G89.18 | — | — | — | 1 | 5 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carcinoma | D002277 | — | C80.0 | 4 | 6 | 2 | — | 3 | 13 |
Syndrome | D013577 | — | — | — | — | 4 | — | 9 | 13 |
Lung neoplasms | D008175 | — | C34.90 | 5 | 2 | 3 | — | 1 | 10 |
Coronary artery disease | D003324 | — | I25.1 | — | — | 2 | — | 7 | 9 |
Non-small-cell lung carcinoma | D002289 | — | — | 5 | 2 | 2 | — | — | 8 |
Infections | D007239 | EFO_0000544 | — | 2 | 3 | 1 | — | 3 | 7 |
Coronary disease | D003327 | — | — | — | — | 2 | — | 4 | 6 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 1 | — | 5 | 6 |
Prostatic neoplasms | D011471 | — | C61 | 3 | 5 | 1 | — | — | 6 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | 2 | 1 | — | 3 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 4 | 3 | — | — | 7 | 12 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 3 | — | — | 7 | 10 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | — | — | 8 | 9 |
Covid-19 | D000086382 | — | U07.1 | 1 | 1 | — | — | 7 | 8 |
Depression | D003863 | — | F33.9 | 3 | 1 | — | — | 3 | 7 |
Melanoma | D008545 | — | — | 5 | 1 | — | — | 1 | 6 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 3 | 2 | — | — | 1 | 5 |
Keratoconus | D007640 | EFO_0004223 | H18.6 | — | 1 | — | — | 4 | 5 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | — | 1 | — | — | 4 | 5 |
Hiv infections | D015658 | EFO_0000764 | B20 | 4 | 1 | — | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Malnutrition | D044342 | EFO_0008572 | E40-E46 | 13 | — | — | — | 2 | 15 |
Hiv | D006678 | — | O98.7 | 1 | — | — | — | 4 | 5 |
Acne vulgaris | D000152 | EFO_0003894 | L70 | 3 | — | — | — | 1 | 4 |
Hemorrhage | D006470 | MP_0001914 | R58 | 1 | — | — | — | 3 | 4 |
Anxiety | D001007 | EFO_0005230 | F41.1 | 1 | — | — | — | 3 | 4 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | — | — | — | 3 | 4 |
Colonic neoplasms | D003110 | — | C18 | 1 | — | — | — | 2 | 3 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 1 | — | — | — | 2 | 3 |
Thrombosis | D013927 | — | — | 1 | — | — | — | 2 | 3 |
Malaria | D008288 | EFO_0001068 | B54 | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cataract | D002386 | EFO_0001059 | H26.9 | — | — | — | — | 6 | 6 |
Cognitive dysfunction | D060825 | — | G31.84 | — | — | — | — | 6 | 6 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | — | — | 5 | 5 |
Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | — | — | — | — | 4 | 4 |
Newborn respiratory distress syndrome | D012127 | — | P22 | — | — | — | — | 4 | 4 |
Aortic valve stenosis | D001024 | EFO_0000266 | — | — | — | — | — | 4 | 4 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | — | — | — | 4 | 4 |
Critical illness | D016638 | — | — | — | — | — | — | 3 | 3 |
Intracranial arteriosclerosis | D002537 | EFO_1000860 | I67.2 | — | — | — | — | 3 | 3 |
Myofascial pain syndromes | D009209 | EFO_1001054 | — | — | — | — | — | 3 | 3 |
Drug common name | Enoblituzumab |
INN | enoblituzumab |
Description | Enoblituzumab is a monoclonal antibody designed for the treatment of cancer. Formerly known as MGA271, the drug is a humanized IgG1κ monoclonal antibody recognizing human B7-H3, a member of the B7 family of immune regulators.
|
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL3545373 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | M6030H73N9 (ChemIDplus, GSRS) |